Feedback / Questions
BAT8006 - Bio-Thera Solutions
https://www.prnewswire.com/news-releases/bio-thera-solutions-announces-first-patient-dosed-in-phase-3-clinical-trial-for-bat8006-an-antibody-drug-conjugate-targeting-folate-receptor--for-the-treatment-of-platinum-resistant-ovarian-cancer-302490679.html
Jun 25, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next